CD274 and neoplasm: Because PD-L1 expression on both tumor cells and cells in the TME can dampen T-cell activation and reinforce T-cell exhaustion [47–51] we initially performed IHC of PD-L1 staining in tumors after three days of treatment with MRTX849, lapatinib, or a combination of the two.